期刊文献+

影响蛋白质药物在聚乳酸-羟基乙酸微球制备过程中稳定性与增加累积释放的方法 被引量:2

Formulation Aspects of Protein Stability and Complete Release in Poly (Lactic-co-glycolic acid) Microspheres
下载PDF
导出
摘要 目的介绍增加乳酸-羟基乙酸聚合物(PLGA)蛋白微球中药物稳定性与蛋白累积释放量的方法。方法根据国内外文献,较全面地总结了PLGA微球中稳定蛋白,解决不完全释放的策略。结果与结论虽然PLGA微球制备与药物释放过程中存在不利于蛋白稳定的因素,但通过选用不同添加剂、优化体外释放介质及装置、改进制备工艺、开发复合材料及复合微球等方法可以有效保存其活性,增加累积释放量。 OBJECTIVE To give a brief introduction of methods which can stabilize encapsulated protein and increase the cumulative release of protein from PLGA microspheres. METHODS On the base of literatures at home and abroad, strategies to improve the stability of protein and facilitate its complete release were generally summarized here. RESULTS AND CONCLUSION Although proteins are unstable in PLGA, by choosing proper additives, optimizing release device and medium in vitro', improving the technique of microspheres fabrication, employing composite polymers, we can preserve their activities and solve the problem of incomplete release.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2008年第2期99-102,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 PLGA 微球 蛋白质 不完全释放 稳定性 PLGA microspheres protein incomplete release stability
  • 相关文献

参考文献21

  • 1BOUISSOU C, POTTER U, ALTROFF H, et al. Controlled release of the fibronectin central cell binding domain from polymeric microspheres [ J ]. J Controlled Release, 2004,95 ( 3 ) :557-66.
  • 2S NCHEZ A, TOB O M, GONZ LEZ L, et al. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha[J]. Eur J Pharm Sci, 2003,18(3-4) :221-229.
  • 3刘玲,葛宇,高俊杰,袁勤生.乳酸-羟乙酸共聚物微球中rhCu,Zn-SOD稳定性研究[J].中国药学杂志,2003,38(3):190-193. 被引量:3
  • 4WEERT M, HOECHSTETTER J, HENNINK W E, et al. The effect of a water/organic solvent interface on the structural stability of lysozyme[ J]. J Controlled Release, 2000,68(3) :351-9.
  • 5CASTELLANOS I J, CRESPO R, GRIEBENOW K. Poly (ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres [ J ]. J Controlled Release, 2003,88( 1 ) :135-145.
  • 6SANDOR M, RIECHEL A, KAPLAN I, et al. Effect of lecithin and MgCO3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly(lactide-co-glycolide) (PLGA) microspheres[ J]. Biochim Biophys Acta, 2002,1570( 1 ) :63-74.
  • 7JAGANATHAN K S, RAO YUB, SINGH P, et al. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly (d, 1-lactic-co-glycolic acid) versus chitosan microspheres[J].Int J Pharm, 2005,294 ( 1-2 ) :23-32.
  • 8PEREZ C, JESS P D, GRIEBENOW K. Preservation of lysozyme structure and function upon encapsulation and release from poly (lactic-co-glycolic) acid microspheres prepared by the water- in-oil-in-water method[ J]. Int J Pharm, 2002, 248 (1-2) : 193- 206.
  • 9P REZ-RODRIGUEZ C, MONTANO N, GONZALEZ K, et al. Stabilization of a-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres [ J ]. J Controlled Release, 2003, 89 ( 1 ) :71-85.
  • 10CASTELLANOS I J, CRUZ G, CRESPO R, et al. Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention [ J ]. J Controlled Release, 2002,81 ( 3 ) : 307-319.

二级参考文献2

共引文献2

同被引文献19

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部